Mark Goldsmith

Mark Goldsmith

Chief Executive Officer at REVOLUTION MEDICINES, INC.

Net worth: 25 M $ as of 2024-02-28

62 year
Health Technology
Finance
Consumer Services

Profile

Mark A.
Goldsmith
is a businessperson who founded Revolution Medicines, Inc. and Cogentus Pharmaceuticals, Inc. and who has been the head of 5 different companies.
He is Chairman, President & Chief Executive Officer at Revolution Medicines, Inc. Dr. Goldsmith is also on the board of Nura Bio, Inc. In his past career Mark A.
Goldsmith
occupied the position of Chairman, President & Chief Executive Officer of Cogentus Pharmaceuticals, Inc., Chairman for Nurix Therapeutics, Inc., Senior Executive-in-Residence at Prospect Venture Partners, Partner at Third Rock Ventures LLC, Chairman of Constellation Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Global Blood Therapeutics, Inc., Senior Vice President for Genencor International, Inc., Member of Roche Group and Assistant Director at The J.
David Gladstone Institutes.
Mark A.
Goldsmith
received an undergraduate degree from Princeton University and a doctorate from The University of California, San Francisco.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-17 858,774 ( 0.52% ) 25 M $ 2024-02-28

Mark Goldsmith active positions

CompaniesPositionStart
REVOLUTION MEDICINES, INC. Chief Executive Officer 2014-10-31
Director/Board Member -
All active positions of Mark Goldsmith

Former positions of Mark Goldsmith

CompaniesPositionEnd
CONSTELLATION PHARMACEUTICALS, INC. Chief Executive Officer 2012-02-29
NURIX THERAPEUTICS, INC. Chief Executive Officer 2014-09-17
Private Equity Investor 2014-12-31
GLOBAL BLOOD THERAPEUTICS, INC. Chief Executive Officer 2014-06-16
Chief Executive Officer 2009-12-17
See the detail of Mark Goldsmith's experience

Training of Mark Goldsmith

Princeton University Undergraduate Degree
The University of California, San Francisco Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark Goldsmith's experience

Connections

99

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
NURIX THERAPEUTICS, INC.

Health Technology

REVOLUTION MEDICINES, INC.

Health Technology

Private companies10

Health Technology

Health Technology

Health Technology

Finance

Finance

Commercial Services

Health Technology

Health Technology

Finance

Health Technology

See company connections
  1. Stock
  2. Insiders
  3. Mark Goldsmith